SBRT (Stereotactic Body Radiation Therapy) in Combination With Nivolumab/Ipilimumab in Renal Cell Carcinoma (RCC) / Kidney Cancer Patients

NCT03065179 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer Metastatic
Kidney Cancer
Kidney Cancer, Stage IV

Interventions

DRUG: Nivolumab/Ipilimumab
RADIATION: SBRT

Sponsor

University of Texas Southwestern Medical Center